ConductScience.org, home

Paper41300973

The Microbiome and Genitourinary Cancers: A New Frontier.

Winslow TB and 4 others. Cancers (Basel), 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. The Microbiome and Genitourinary Cancers: A New Frontier. Papers, record 41300973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300973

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Microbiome and Genitourinary Cancers: A New Frontier.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-09-25
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Winslow TBTimothy Bhttps://orcid.org/0009-0001-0605-1971
2Gupta SSophia
3Vaddaraju VSVedha Sai
4Guercio BJBrendan Jhttps://orcid.org/0000-0001-6296-2473
5Sahasrabudhe DMDeepak M

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References104

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138583184CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.Cancer Discov2024https://conductscience.org/library/papers/38583184PubMed
233303685Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.Science2021https://conductscience.org/library/papers/33303685PubMed
338588588Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.Cancer Discov2024https://conductscience.org/library/papers/38588588PubMed
434792538Treatment Selection in First-line Metastatic Renal Cell Carcinoma-The Contemporary Treatment Paradigm in the Age of Combination Therapy: A Review.JAMA Oncol2022https://conductscience.org/library/papers/34792538PubMed
537764869A Large Genetic Causal Analysis of the Gut Microbiota and Urological Cancers: A Bidirectional Mendelian Randomization Study.Nutrients2023https://conductscience.org/library/papers/37764869PubMed
626152743Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors.Clin Cancer Res2015https://conductscience.org/library/papers/26152743PubMed
737697271Causal associations between gut microbiota and urological tumors: a two-sample mendelian randomization study.BMC Cancer2023https://conductscience.org/library/papers/37697271PubMed
836398663Probiotics enhances anti-tumor immune response induced by gemcitabine plus cisplatin chemotherapy for urothelial cancer.Cancer Sci2023https://conductscience.org/library/papers/36398663PubMed
938024475Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215).EClinicalMedicine2023https://conductscience.org/library/papers/38024475PubMed
1032297948Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors.JAMA Netw Open2020https://conductscience.org/library/papers/32297948PubMed
1133850311Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids.Cell Mol Immunol2021https://conductscience.org/library/papers/33850311PubMed
1230258117Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate.Sci Rep2018https://conductscience.org/library/papers/30258117PubMed
1338227898Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.J Clin Oncol2024https://conductscience.org/library/papers/38227898PubMed
1438169949Microbial metabolites are involved in tumorigenesis and development by regulating immune responses.Front Immunol2023https://conductscience.org/library/papers/38169949PubMed
1538572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1628260787Dysbiosis and the immune system.Nat Rev Immunol2017https://conductscience.org/library/papers/28260787PubMed
1730675064A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.Nature2019https://conductscience.org/library/papers/30675064PubMed
1838652128Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study.Int J Surg2024https://conductscience.org/library/papers/38652128PubMed
1929311384Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.J Immunol2018https://conductscience.org/library/papers/29311384PubMed
2035039521Microbiome differential abundance methods produce different results across 38 datasets.Nat Commun2022https://conductscience.org/library/papers/35039521PubMed

See all 104 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42768754Long-Term or Recurrent Antibiotic Use During Childhood or Adolescence and the Risk of Kidney Cancer: A Cohort Study.Cancer Med2026https://conductscience.org/library/papers/42768754PubMed
41681968Decoding Microbiota in Genitourinary Oncology: Biological Mechanisms and Clinical Implications-A Narrative Review.Cancers (Basel)2026https://conductscience.org/library/papers/41681968PubMed
41658610Decoding the microbial blueprint of pancreatic cancer.Front Med (Lausanne)2026https://conductscience.org/library/papers/41658610PubMed
41596284Dysbiosis-Mediated Regulation of Stem Cells the First Hit for Cancer Generation.Int J Mol Sci2026https://conductscience.org/library/papers/41596284PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41300973

GET https://conductscience.org/api/papers/v1/41300973/references?page=2